Analystreport

Collegium Pharmaceutical (COLL) had its price target lowered by Needham & Company LLC from $56.00 to $54.00. They now have a "buy" rating on the stock.

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com